Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway
Yijiong Li(First Affiliated Hospital of Hebei Medical University), Xin Wang(Qingdao National Laboratory for Marine Science and Technology)
Cited by 12
Related Papers
Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease
|International Journal of Molecular Sciences|2021|41